<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=314834185700910&amp;ev=PageView&amp;noscript=1">

New Update: Healthcare Costs Increasing by Over 60% in Some States. Will you be impacted?

Learn More

Charles River Laboratories International Employees Face Potential Health Care Cost Increases in 2026

image-table

Healthcare Provider Update: Healthcare Provider for Charles River Laboratories International Charles River Laboratories International, Inc. is primarily known for providing various preclinical and clinical laboratory services to the pharmaceutical, medical device, and biotechnology industries. Their healthcare offerings include specialized services such as toxicology testing, bioanalysis, and laboratory research, but they do not act as a traditional healthcare insurance provider or offer direct healthcare services. Potential Healthcare Cost Increases in 2026 In 2026, significant premium increases are anticipated for health insurance plans within the Affordable Care Act (ACA) marketplace, driven by escalating medical costs and the possible expiration of enhanced federal subsidies. Some states may see hikes exceeding 60%, particularly affecting low and middle-income families reliant on these plans. With reports indicating that over 90% of marketplace enrollees could face premium raises of 75% or more, the landscape for healthcare affordability will become increasingly challenging, prompting consumers and companies alike to reassess their healthcare strategies and financial planning. Click here to learn more

'Charles River Laboratories International employees should prepare for 2026 by reviewing upcoming benefit changes and exploring ways to manage rising out-of-pocket health care costs.' - Paul Bergeron, a representative of The Retirement Group, a division of Wealth Enhancement.

'Charles River Laboratories International employees can better navigate rising health care expenses in 2026 by understanding benefit adjustments early and making informed plan selections,' - Tyson Mavar, a representative of The Retirement Group, a division of Wealth Enhancement.

In this article, we’ll examine:

  1. Why increasing health care costs are pushing Charles River Laboratories International employers to pass more expenses onto employees.

  2. The approaches companies are using to handle cost pressures, including changes in plan design and pharmacy benefit modifications.

  3. How marketplace premium hikes and medical cost trends affect overall health care affordability.

In 2026, Charles River Laboratories International employees may bear a greater share of health care expenses as costs keep climbing.

Many large U.S. companies, including those such as Charles River Laboratories International, are preparing to adjust benefit structures to counter rising health care expenses. Mercer’s recent survey of 711 U.S. employers with 500 or more employees found that 51% are “likely” or “very likely” to raise deductibles, coinsurance, or out-of-pocket maximums in 2026—up from 45% who said the same for 2025. 1  

Despite cost-saving actions, employers’ health care costs rose by 4.5% in 2024 and are expected to climb another 5.8% in 2025; absent these actions, Mercer estimates that costs could go up by ~8%. 2  A key contributing factor is the high price of GLP-1 medications for diabetes and weight loss, averaging around $1,000 per patient per month. 1  The survey also found that 77% of employers rated managing GLP-1 costs as extremely or very important. 1  Although many companies—including those in the energy sector—have expanded GLP-1 coverage, growing concerns suggest such plans may be untenable by 2026.

Shifting Employer Approaches to Benefits

Previously, employers hesitated to raise deductibles because of tight labor markets and concerns about affordability. Today, with economic uncertainty and slower wage growth, cost management may be taking precedence over hiring and retention efforts in some cases. In 2026, 35% of large firms intend to offer unconventional medical plan options—such as copay-based models aimed at reducing costs while maintaining quality. 1  Moreover, 61% are evaluating alternatives to traditional pharmacy benefit arrangements to bring more clarity to drug pricing and pharmacy benefit manager (PBM) services. 1

Rising Costs in the Individual Market

The pressure extends beyond employer-sponsored coverage. The ACA marketplace is slated to experience some of its biggest premium increases in over five years. According to state filings, 2026 premiums could jump dramatically—UnitedHealthcare in New York is seeking increases of up to 66.4%, 3  Arkansas expects an average increase of 36.1%, 4  and Florida Blue is looking at 27%. 5  If enhanced federal subsidies expire at the end of 2025, millions could be exposed to the full impact of these higher premiums.

Why Costs Are Rising Across the Board

Medical cost trends are projected to increase by 7–10% annually—far exceeding general inflation—driven by factors like brand name medications, hospital services, and specialist care. Regulatory changes are adding further pressure. Insurer earnings also contribute, as several major carriers posted record profits in 2024 while launching multibillion-dollar stock buybacks.

Key Take-Away for Charles River Laboratories International Workers

With 51% of employers planning to transfer more health care costs onto workers—and ACA premiums rising sharply—2026 may become a critical year for health care affordability. Charles River Laboratories International employees who familiarize themselves with upcoming benefit changes, optimize HSA/FSA contributions, and choose their 2026 plan with care may offset some of the added costs. Otherwise, households could see thousands in extra spending for equal—or even reduced—coverage.

Featured Video

Articles you may find interesting:

Loading...

Sources:

1.  Mercer. “ U.S. Employers Rethinking Benefit Strategy for 2026 amid Rapidly Rising Costs .”  Mercer Newsroom , 16 July 2025.

2. Fierce Healthcare. ' Mercer survey: Employers may make a return to healthcare cost-shifting strategies ,' by Paige Minemyer. 16 Jul 2025. 

3. New York State Department of Financial Services. ' 2026 Individual and Small Group Requested Rate Actions ,' 2 June 2025. 

4. ACHI. ' Arkansas Insurers File Proposed Rate Increases for 2026 ,' by Chris Ray. 8 Aug. 2025. 

5. Insurance Newsnet. ' Florida Blue among companies proposing double-digit healthcare increases ,' by Christine Sexton. 12 Aug. 2025. 

Other Resources:

1.  Ortaliza, Jared, et al. “How Much and Why ACA Marketplace Premiums Are Going Up in 2026.”  Peterson-KFF Health System Tracker , 6 Aug. 2025.

2.  New York State Department of Financial Services. “2026 Individual and Small Group Requested Rate Actions – Additional Information.”  DFS Prior Approval Portal , accessed 13 Aug. 2025.

3.  Sexton, Christine. “Watch Out for Double-Digit Health Insurance Increases in 2026.”  The Florida Phoenix , 11 Aug. 2025.

4.  Federal Trade Commission.  Specialty Generic Drugs: A Growing Profit Center for Vertically Integrated Pharmacy Benefit Managers. Second Interim Staff Report.  14 Jan. 2025. pp. 5–6, 19–20, 32–34.

What type of retirement savings plan does Charles River Laboratories International offer?

Charles River Laboratories International offers a 401(k) retirement savings plan to its employees.

Does Charles River Laboratories International match employee contributions to the 401(k) plan?

Yes, Charles River Laboratories International provides a matching contribution to employee 401(k) contributions, subject to certain limits.

What is the eligibility requirement to participate in the 401(k) plan at Charles River Laboratories International?

Employees of Charles River Laboratories International are generally eligible to participate in the 401(k) plan after completing a specified period of service.

How can employees of Charles River Laboratories International enroll in the 401(k) plan?

Employees can enroll in the 401(k) plan through the company’s benefits portal or by contacting the HR department at Charles River Laboratories International.

What investment options are available in the 401(k) plan at Charles River Laboratories International?

Charles River Laboratories International offers a variety of investment options in its 401(k) plan, including mutual funds, target-date funds, and other investment vehicles.

Can employees of Charles River Laboratories International take loans against their 401(k) savings?

Yes, Charles River Laboratories International allows employees to take loans against their 401(k) savings, subject to the plan's rules and regulations.

What is the vesting schedule for employer contributions in the 401(k) plan at Charles River Laboratories International?

The vesting schedule for employer contributions at Charles River Laboratories International may vary, but typically follows a graded vesting schedule over several years.

How often can employees of Charles River Laboratories International change their 401(k) contributions?

Employees can change their 401(k) contribution amounts at any time, subject to the plan's guidelines set by Charles River Laboratories International.

Are there any fees associated with the 401(k) plan at Charles River Laboratories International?

Yes, there may be administrative fees associated with the 401(k) plan at Charles River Laboratories International, which are disclosed in the plan documents.

What resources does Charles River Laboratories International provide to help employees manage their 401(k) investments?

Charles River Laboratories International provides educational resources, access to financial advisors, and online tools to help employees manage their 401(k) investments.

With the current political climate we are in it is important to keep up with current news and remain knowledgeable about your benefits.
Update: In 2024, Charles River Laboratories International has announced a significant overhaul of its 401(k) plan, which includes increasing the company match percentage and introducing a new vesting schedule. This change is aimed at improving employee retention and competitive positioning. The update is crucial in the current economic environment where employees are seeking better retirement benefits amid economic uncertainty.
Restructuring Layoffs: Charles River Laboratories announced a workforce reduction in early 2024. The company is consolidating its facilities and focusing on higher-margin services, resulting in layoffs primarily affecting administrative and support roles. This restructuring is part of their broader strategy to streamline operations and reduce costs amidst economic uncertainty.
Charles River Laboratories International Stock Options and RSUs 2022 Stock Options: Charles River Laboratories International granted stock options primarily to executives and senior management. These options typically had a vesting period of 4 years with annual vesting in 25% increments. RSUs: RSUs were awarded to a broader employee base, including senior executives and key employees. These units generally vested over a period of 3 years with a performance component tied to company goals. Availability: Stock options and RSUs were part of the company's broader compensation package to attract and retain top talent, with specific allocations based on role and performance. 2023 Stock Options: Charles River Laboratories International continued to offer stock options, mainly to higher-level executives and employees in strategic roles. The options typically had a 4-year vesting schedule with performance criteria. RSUs: In 2023, Charles River Laboratories International expanded its RSU program to include mid-level management. The vesting schedule remained similar, with a 3-year timeline and performance metrics. Availability: Both stock options and RSUs were used to incentivize employees and align their interests with company performance, with allocation levels varying by position and individual performance. 2024 Stock Options: For 2024, Charles River Laboratories International maintained its stock option program, focusing on key positions and high performers. The vesting schedule continued to be spread over 4 years. RSUs: The RSU program for 2024 included adjustments to address market conditions and employee retention. The vesting period stayed at 3 years, with an increased emphasis on performance-based criteria. Availability: The stock options and RSUs were integral to the company’s compensation strategy, aimed at rewarding contributions and aligning employee interests with the company’s long-term goals.
Charles River Laboratories International offers a range of health benefits designed to support employee well-being. For the years 2022, 2023, and 2024, the company has implemented comprehensive healthcare coverage including medical, dental, and vision insurance. In 2023, Charles River Laboratories introduced a new Health Savings Account (HSA) option for employees, allowing for more flexible contributions and tax advantages. Additionally, the company provides an Employee Assistance Program (EAP) to support mental health and work-life balance. Recent updates also include enhanced telehealth services and expanded coverage for preventive care. In the current economic and political climate, Charles River Laboratories' healthcare offerings play a crucial role in attracting and retaining talent. As the investment landscape evolves, the company's commitment to comprehensive healthcare benefits helps mitigate employee concerns about medical costs and access to care. This focus on health benefits is particularly relevant amid ongoing discussions about healthcare policy reforms and economic fluctuations, which can impact both corporate budgets and employee well-being. As such, Charles River Laboratories' proactive approach to healthcare is an important factor in maintaining employee satisfaction and organizational stability.
New call-to-action

Additional Articles

Check Out Articles for Charles River Laboratories International employees

Loading...

For more information you can reach the plan administrator for Charles River Laboratories International at 251 Ballardvale St. Wilmington, MA 1887; or by calling them at 1-781-222-6000.

https://www.businessinsider.com/ https://www.reuters.com/ https://www.bloomberg.com/asia https://www.marketwatch.com/ http://www.thelayoff.com/ http://www.sec.gov/ http://www.fidelity.com/ http://www.morningstar.com/ http://www.bloomberg.com/ https://www.thelayoff.com/ https://www.businessinsider.com/ https://www.reuters.com/ https://www.bloomberg.com/asia

*Please see disclaimer for more information

Relevant Articles

Check Out Articles for Charles River Laboratories International employees